Medication adherence in patients with asthma using once-daily versus twice-daily ICS/LABAs

References

• Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention 2018 [updated Mar 2018]. Available from: http://ginasthma.org/2018-gina-report-global-strategy-for-asthma-management-and-prevention/.
   Google Scholar
• National Heart Lung and Blood Institute. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. 2007.
   Google Scholar
• Price DB, Colice G, Israel E, Roche N, Postma DS, Guilbert TW, van Aalderen WMC, Grigg J, Hillyer EV, Thomas V, et al. Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler. ERJ Open Res. 2016;2:00106-2015. doi:10.1183/23120541.00106-2015.
   PubMedGoogle Scholar
• US Food and Drug Administration. New Drug Application (NDA): 204275 (Breo Ellipta) 2013 [cited 2018 Dec 19]. Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204275.
   Google Scholar
• US Food and Drug Administration. New Drug Application (NDA): 021929 (Symbicort) 2006 [cited 2018 Dec 19]. Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021929.
   Google Scholar
• US Food and Drug Administration. New Drug Application (NDA): 021077 (Advair Diskus) 2000 [updated 2017; cited 2018 Dec19]. Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021077.
   Google Scholar
• US Food and Drug Administration. New Drug Application (NDA): 021254 (Advair HFA) 2006 [cited 2019 Jun 20]. Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021254.
   Google Scholar
• Wu AC, Butler MG, Li L, Fung V, Kharbanda EO, Larkin EK, Vollmer WM, Miroshnik I, Davis RL, Lieu TA, et al. Primary adherence to controller medications for asthma is poor. Ann Am Thorac Soc. 2015;12:161–6. doi:10.1513/AnnalsATS.201410-459OC.
   PubMed Web of Science ®Google Scholar
• Makhinova T, Barner JC, Richards KM, Rascati KL. Asthma controller medication adherence, risk of exacerbation, and use of rescue agents among texas medicaid patients with persistent asthma. J Manag Care Spec Pharm. 2015;21:1124–1132. doi:10.18553/jmcp.2015.21.12.1124.
   PubMed Web of Science ®Google Scholar
• Boutopoulou B, Koumpagioti D, Matziou V, Priftis KN, Douros K. Interventions on adherence to treatment in children with severe asthma: a systematic review. Front Pediatr. 2018;6:232.
   PubMed Web of Science ®Google Scholar
• Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MC, Verhamme KM. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015;45:396–407. doi:10.1183/09031936.00075614.
   PubMed Web of Science ®Google Scholar
• Gold LS, Yeung K, Smith N, Allen-Ramey FC, Nathan RA, Sullivan SD. Asthma control, cost and race: results from a national survey. J Asthma. 2013;50:783–90. doi:10.3109/02770903.2013.795589.
   PubMed Web of Science ®Google Scholar
• Stern L, Berman J, Lumry W, Katz L, Wang L, Rosenblatt L, Doyle JJ. Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data. Ann Allergy Asthma Immunol. 2006;97:402–8. doi:10.1016/S1081-1206(10)60808-3.
   PubMed Web of Science ®Google Scholar
• Delea TE, Stanford RH, Hagiwara M, Stempel DA. Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs. Curr Med Res Opin. 2008;24:3435–42. doi:10.1185/03007990802557344.
   PubMed Web of Science ®Google Scholar
• Dima AL, Hernandez G, Cunillera O, Ferrer M, de Bruin M, Group A-L. Asthma inhaler adherence determinants in adults: systematic review of observational data. Eur Respir J. 2015;45:994–1018. doi:10.1183/09031936.00172114.
   PubMed Web of Science ®Google Scholar
• Makela MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med. 2013;107:1481–90. doi:10.1016/j.rmed.2013.04.005.
   PubMed Web of Science ®Google Scholar
• Price D, Robertson A, Bullen K, Rand C, Horne R, Staudinger H. Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study. BMC Pulm Med. 2010;10:1. doi:10.1186/1471-2466-10-1.
   PubMed Web of Science ®Google Scholar
• Wells KE, Peterson EL, Ahmedani BK, Williams LK. Real-world effects of once vs greater daily inhaled corticosteroid dosing on medication adherence. Ann Allergy Asthma Immunol. 2013;111:216–20. doi:10.1016/j.anai.2013.06.008.
   PubMed Web of Science ®Google Scholar
• Dal Negro RW, Bonadiman L, Turco P. Fluticasone furoate/vilanterol 92/22 mug once-a-day vs beclomethasone dipropionate/formoterol 100/6 mug b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma. Multidiscip Respir Med. 2018;13:18. doi:10.1186/s40248-018-0131-x.
   PubMed Web of Science ®Google Scholar
• de Llano LP, Sanmartin AP, González-Barcala FJ, Mosteiro-Añón M, Abelaira DC, Quintas RD, Ventosa MM. Assessing adherence to inhaled medication in asthma: Impact of once-daily versus twice-daily dosing frequency. The ATAUD study. J Asthma. 2018;55:933–8. doi:10.1080/02770903.2018.1426769.
   PubMed Web of Science ®Google Scholar
• Navaratnam P, Friedman HS, Urdaneta E. Treatment with inhaled mometasone furoate reduces short-acting beta(2) agonist claims and increases adherence compared to fluticasone propionate in asthma patients. Value Health. 2011;14:339–46. doi:10.1016/j.jval.2011.01.001.
   PubMed Web of Science ®Google Scholar
• Guest JF, Davie AM, Ruiz FJ, Greener MJ. Switching asthma patients to a once-daily inhaled steroid improves compliance and reduces healthcare costs. Prim Care Respir J 2005;14:88–98. doi:10.1016/j.pcrj.2005.01.002.
   PubMedGoogle Scholar
• Friedman HS, Navaratnam P, McLaughlin J. Adherence and asthma control with mometasone furoate versus fluticasone propionate in adolescents and young adults with mild asthma. J Asthma. 2010;47:994–1000. doi:10.1080/02770903.2010.513076.
   PubMed Web of Science ®Google Scholar
• Stanford RH, Averell C, Parker ED, Blauer-Peterson C, Reinsch TK, Buikema AR. Assessment of adherence and asthma medication ratio (AMR) for a once-daily and twice-daily inhaled corticosteroid/long acting beta agonist (ICS/LABA) for asthma. J Allergy Clin Immunol Pract. 2019;7:14-1496.e7. doi:10.1016/j.jaip.2018.12.021.
   Web of Science ®Google Scholar
• Atsuta R, Takai J, Mukai I, Kobayashi A, Ishii T, Svedsater H. Patients with asthma prescribed once-daily fluticasone furoate/vilanterol or twice-daily fluticasone propionate/salmeterol as maintenance treatment: analysis from a claims database. Pulm Ther. 2018;4:135. doi:10.1007/s41030-018-0084-4.
   PubMedGoogle Scholar
• Marceau C, Lemiere C, Berbiche D, Perreault S, Blais L. Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma. J Allergy Clin Immunol. 2006;118:574–81. doi:10.1016/j.jaci.2006.06.034.
   PubMed Web of Science ®Google Scholar
• Williams LK, Peterson EL, Wells K, Ahmedani BK, Kumar R, Burchard EG, Chowdhry VK, Favro D, Lanfear DE, Pladevall M, et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol. 2011;128:1185–91. doi:10.1016/j.jaci.2011.09.011.
   PubMed Web of Science ®Google Scholar
• Williams LK, Pladevall M, Xi H, Peterson EL, Joseph C, Lafata JE, Ownby DR, Johnson CC. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114:1288–93. doi:10.1016/j.jaci.2004.09.028.
   PubMed Web of Science ®Google Scholar
• Price D, Harrow B, Small M, Pike J, Higgins V. Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians. World Allergy Organ J. 2015;8:26. doi:10.1186/s40413-015-0075-y.
   PubMed Web of Science ®Google Scholar
• Ismaila A, Corriveau D, Vaillancourt J, Parsons D, Stanford R, Su Z, Sampalis JS. Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients. Curr Med Res Opin. 2014;30:1417–25. doi:10.1185/03007995.2014.908827.
   PubMed Web of Science ®Google Scholar
• Oland AA, Booster GD, Bender BG. Psychological and lifestyle risk factors for asthma exacerbations and morbidity in children. World Allergy Organ J. 2017;10:35doi:10.1186/s40413-017-0169-9.
   PubMed Web of Science ®Google Scholar
• Gillisen A. Patient’s adherence in asthma. J Physiol Pharmacol. 2007;58:205–22.
   PubMed Web of Science ®Google Scholar